Eritrea vs Iraq: Cause of death, by non-communicable diseases, ages 15-59, male
Eritrea
46.2%
in 2021
Iraq
45.4%
in 2021
Eritrea rank
109th
Iraq rank
112th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Eritrea
- Iraq
How they compare
Eritrea currently reports 46.2% against 45.4% in Iraq, a difference of 0.8%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Iraq ahead.
Eritrea ranks 109th and Iraq ranks 112th of 185 countries.
Across the 3 decades both report, Eritrea averaged higher in 2 and Iraq in 1.
Head to head by decade
| Decade | Eritrea | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.9% | 47.4% | 8.5% | Iraq |
| 2010s | 45.8% | 39.2% | 6.7% | Eritrea |
| 2020s | 46.9% | 44.6% | 2.3% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Eritrea or Iraq?
- Eritrea, at 46.2% against 45.4% in Iraq as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Eritrea and Iraq?
- 0.8%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Iraq?
- 6 years are reported by both, from 2000 to 2021.
- How do Eritrea and Iraq rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Eritrea ranks 109th and Iraq ranks 112th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.